Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (Q61534858)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30712900%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

meta-analysis

0 references

title

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30712900%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

1 reference

1 reference

99

Faiez Zannad

0 references

Luigi Tavazzi

85

Luigi Tavazzi

0 references

Stella Trompet

89

Stella Trompet

0 references

Eugene Braunwald

8

Eugene Braunwald

0 references

John Kjekshus

44

John Kjekshus

0 references

Wolfgang Koenig

47

Wolfgang Koenig

0 references

Salim Yusuf

98

Salim Yusuf

0 references

Andrew Tonkin

88

Andrew Tonkin

0 references

Sarah Parish

66

Sarah Parish

0 references

Ian C. Marschner

1 reference

ORCID Public Data File 2021

author name string

Cholesterol Treatment Trialists' Collaboration

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30712900%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

language of work or name

English

0 references

publication date

1 February 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30712900%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30712900%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

volume

393

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30712900%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

page(s)

407-415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30712900%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

issue

10170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30712900%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials

21 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998-2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Initiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Myths and facts concerning the use of statins in very old patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Preventive health care in elderly people needs rethinking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Interpretation of the evidence for the efficacy and safety of statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Rosuvastatin in older patients with systolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Statins for the primary prevention of cardiovascular disease in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Statins in the elderly: a patient-focused approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

The safety of statins in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Myopathy in older people receiving statin therapy: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Protocol for analyses of adverse event data from randomized controlled trials of statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2931942-1

7 January 2021

Statins for the prevention of dementia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30712900

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/S0140-6736(18)31942-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30712900%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30712900%20AND%20SRC:MED&resulttype=core&format=json

21 April 2020

1 reference